BOOK · [068]
Reputation and Power: Organizational Image and Pharmaceutical Regulation at the FDA
Reputation and Power: Organizational Image and Pharmaceutical Regulation at the FDA
Regulatory History
Carpenter's institutional history shows how the FDA deliberately cultivated a reputation for vigilance as a political resource, making it progressively harder to approve drugs regardless of benefit-risk calculus. Balaji credits it with teaching him how regulatory capture works at the bureaucratic level — directly informing his pro-biotech, pro-longevity reform arguments.
Endorsed By
1 PERSON-
Balaji Srinivasan
Balaji credits it with teaching him how regulatory capture works at the bureaucratic level, directly informing his arguments for pro-biotech and longevity-science reform.